VanGln-1: A Protein Involved in Multiple Cellular Processes and Potential Drug Targets

Target Name: VANGL1

NCBI ID: G81839

VanGln-1: A Protein Involved in Multiple Cellular Processes and Potential Drug Targets

VanGln-1 (LPP2) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the serine/threonine protein kinase (SMPK) family and is involved in a variety of cellular processes, including cell signaling, cell survival, and tissue repair.

One of the unique features of VanGln-1 is its ability to interact with several different protein substrates, including casein kinase (CK) 3,4, and 5, as well as the protein kinase A1 (PKA1). This interacting ability makes VanGln- 1 a potential drug target, as it can be targeted by small molecules that can inhibit or activate these protein interactions.

In addition to its potential as a drug target, VanGln-1 is also a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because its expression is often increased in these types of diseases, and may be a Useful indicator of the severity or progression of these conditions.

One of the ways that VanGln-1 is involved in disease is its role in the regulation of cell death. In neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, VanGln-1 has been shown to contribute to the progression of neurodegeneration by promoting the survival of damaged neurons and glial cells. This may be because VanGln-1 helps to regulate the production of reactive oxygen species (ROS), which can damage cellular components and contribute to the development of neurodegeneration.

Another way that VanGln-1 is involved in disease is its role in tissue repair. In diseases such as diabetes, wounds, and radiation-induced tissue damage, VanGln-1 has been shown to play a role in promoting the repair of damaged tissue by regulates the production of pro-inflammatory cytokines. This may be because VanGln-1 helps to prevent the excessive production of these cytokines, which can contribute to tissue inflammation and the development of chronic diseases.

In addition to its role in disease, VanGln-1 is also a potential drug target because of its unique structure and the fact that it is expressed in multiple tissues. This makes it a challenging target, as it is difficult to predict the effects of a drug on a protein that is expressed in multiple tissues and is involved in multiple cellular processes. However, there is ongoing research into the potential targeting of VanGln-1 as a drug target, both alone and in combination with other treatments.

Overall, VanGln-1 is a protein that is involved in a variety of cellular processes and has been implicated in the development and progression of several diseases. As a potential drug target and biomarker, it is an attractive target for researchers to explore as a means of developing new treatments for a variety of conditions.

Protein Name: VANGL Planar Cell Polarity Protein 1

More Common Targets